Menu

Tetrahexyldecyl Ascorbate

Also known as: THD ascorbate, Tetra-isopalmitoyl ascorbic acid, Ascorbyl tetraisopalmitate

An oil-soluble vitamin C derivative used in skincare, with promising but formula-dependent clinical evidence.

Golden oil under a glass pipette with a restrained curl of orange peel
Editorial illustration

Tetrahexyldecyl ascorbate is an oil-soluble vitamin C derivative designed for use in the lipid phase of skincare. Small trials of finished products report improvements in pigmentation or photoaged skin, but conversion to active ascorbic acid in human skin and superiority to other vitamin C forms are not well established. Evidence from multi-ingredient formulas cannot be credited to this derivative alone.2, 3

  • Oil-soluble vitamin C derivative1, 2
  • More formulation-stable than free ascorbic acid in some systems1, 2
  • Must be converted or act through the finished formula1, 2
  • Clinical studies often include other actives1, 2

What is Tetrahexyldecyl Ascorbate?

Adding long fatty chains changes where the molecule dissolves and how a formulator can deliver it. It also means research on water-soluble L-ascorbic acid should not automatically be transferred to THD ascorbate.1, 2

Where it comes from

Natural sources

  • Derived conceptually from vitamin C and fatty-acid components

How it's made

Commercial THD ascorbate is an esterified, purified vitamin C derivative.

What it does in products

  • Antioxidant skincare active
  • Tone-evening formula
  • Oil-phase vitamin C derivative

Benefits

Uneven tone and photoaging

limited evidence

Small trials of THD-ascorbate-containing formulas report improvements in pigmentation and visible photoaging.2, 3

Studies are short and often test multiple actives, preventing ingredient-specific attribution.

Greater penetration than L-ascorbic acid

insufficient evidence

Oil solubility is a formulation property, but robust head-to-head clinical superiority has not been established.1, 2

Penetration claims depend on vehicle, dose, conversion, and the measured skin compartment.

Evidence scope and limitations

Topical cosmetic THD ascorbate is covered; oral vitamin C and other topical derivatives are separate interventions.

  • Trials are small and frequently multi-ingredient.
  • Direct conversion and comparative-effectiveness data are limited.

Evidence last checked: 2026-09-28

Side effects & safety

Stinging, redness, or breakouts from the finished formula (uncommon)Patch test if reactive; other formula components may be responsible.

Safety considerations

  • Topical vitamin C derivatives are generally not subject to a specific pregnancy warning, but confirm complex active routines with a clinician.
  • Not for: Known allergy or persistent irritation
2, 3

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In skincare studies and products

Commercial formulas use varied low-percentage to higher single-digit ranges; clinical results apply only to the tested formula and schedule.

2, 3

Regulatory status

  • A cosmetic ingredient, not an FDA-approved treatment for melasma or photoaging.
  • INCI name on cosmetic labels: Tetrahexyldecyl Ascorbate.
4

Derivative evidence stays with the derivative

Vitamin C forms differ in charge, solubility, stability, and conversion. A trial of L-ascorbic acid cannot prove THD ascorbate works at the same percentage, and a THD combination serum cannot isolate THD's share of the result.

2, 3

Frequently asked questions

Is THD ascorbate the same as vitamin C?

It is a vitamin C derivative, not free L-ascorbic acid.2, 3

Is it more effective than L-ascorbic acid?

There is not enough direct comparative clinical evidence to make that claim.2, 3

The bottom line

THD ascorbate is a useful oil-soluble formulation option, but its clinical story is promising rather than settled and remains product-specific.

References

  1. Tetrahexyldecyl ascorbate: compound summary. PubChem, National Library of Medicine (2026) · ingredient monograph · CID 10260680
  2. Prospective randomized double-blind comparative study of topical acetyl zingerone with tetrahexyldecyl ascorbate versus tetrahexyldecyl ascorbate alone on facial photoaging. Journal of Cosmetic Dermatology (2024) · randomized trial · PMID 38525606
  3. Open-label topical application of tetrahexyldecyl ascorbate and acetyl zingerone containing serum improves the appearance of photoaging and uneven pigmentation. Journal of Cosmetic Dermatology (2024) · primary study · PMID 38634176
  4. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated. U.S. Food and Drug Administration (2013) · government guidance

Revision history

  1. Initial publication with claim-level citations, formulation limits, safety context, and editorial evidence review.